Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

FAM19A4 and hsa-miR124-2 Double Methylation as Screening for ASC-H- and CIN1 HPV-Positive Women

11 Apr 2024

Abstract excerpt

The DNA methylation levels of host cell genes increase with the severity of the cervical intraepithelial neoplasia (CIN) grade and are very high in cervical cancer. Our study aims to evaluate FAM19A4 and hsa-miR124-2 methylation in Atypical Squamous cells with high-grade squamous intraepithelial lesions (ASC-H) and in CIN1, defined as low-grade squamous intraepithelial lesions (LSILs) by the Bethesda...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer-related gene regulation
Share to Cervical Cancer and HPV Research
Share to Epigenetics and DNA Methylation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38668267
DOI: 10.3390/pathogens13040312

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

FAM19A4 and hsa-miR124-2 Double Methylation as Screening for ASC-H- and CIN1 HPV-Positive WomenPMID 38668267Read ↗

FAM19A4/miR124-2 Methylation Testing and Human Papillomavirus (HPV) 16/18 Genotyping in HPV-Positive Women Under the Age of 30 Years.Semantic proximity Read ↗

Cervical cancer risk in HPV-positive women after a negative FAM19A4/mir124-2 methylation test: A post hoc analysis in the POBASCAM trial with 14 year follow-up.Semantic proximity Read ↗

FAM19A4/miR124‐2 methylation in invasive cervical cancer: A retrospective cross‐sectional worldwide studySemantic proximity Read ↗

Performance of DNA methylation‐based biomarkers in the cervical cancer screening program of northern Portugal: A feasibility studySemantic proximity Read ↗

Cervix cytology samples revealed increased methylation of the human markers FAM19A4 / miR124‐2 up to 8 years before adenocarcinomaSemantic proximity Read ↗

A novel methylation-detection panel for HPV associated high-grade squamous intraepithelial lesion and cervical cancer screeningSemantic proximity Read ↗

A novel methylation-detection panel for HPV associated high-grade squamous intraepithelial lesion and cervical cancer screeningSemantic proximity Read ↗

Reliable identification of women with CIN3+ using hrHPV genotyping and methylation markers in a cytology-screened referral population.Semantic proximity Read ↗

Role of genomic DNA methylation in detection of cytologic and histologic abnormalities in high risk HPV-infected womenSemantic proximity Read ↗

Research progress of DNA methylation in the screening of cervical cancer and precancerous lesionsSemantic proximity Read ↗

Full genotyping and FAM19A4/miR124-2 methylation analysis in high-risk human papillomavirus-positive samples from women over 30 years participating in cervical cancer screening in Örebro, Sweden.Semantic proximity Read ↗

Virtues and Weaknesses of DNA Methylation as a Test for Cervical Cancer PreventionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.